In October 2009, Chase Sun was listed on Shenzhen Stock Exchange (Stock Code: 300026), becoming one of the first GEM listed companies, and the highest share price of China's A-share market at that time. After going public, Chase Sun continued to explore investment opportunities, and take into account growth and profitability to build a layout of coordinated development among industries. Relying on the spirit of independent innovation, the company has been listed in China potential enterprise list in Forbes for three consecutive years, ranking the 4th in the list of core competitiveness of listed pharmaceutical companies selected by SFDA Southern Medicine Economic Research Institute, being rated as the most potential growth GEM company in the 7th China’s Financial Annual Champion Awards, the top 20 listed companies in 2011 China Growth Enterprise Market, and won the key high-tech enterprises of the national torch plan and small technological giant enterprises in Tianjin.
